Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Narcolepsy01:07

Narcolepsy

769
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
769
Sedatives and Hypnotics Drugs: Benzodiazepines01:19

Sedatives and Hypnotics Drugs: Benzodiazepines

1.2K
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
1.2K
Sedatives and Hypnotics: Overview01:23

Sedatives and Hypnotics: Overview

2.0K
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
2.0K
Sleepwalking and Sleep Talking01:17

Sleepwalking and Sleep Talking

1.4K
Somnambulism, commonly known as sleepwalking, involves individuals engaging in activities ranging from simple walking to more complex behaviors such as driving. Sleepwalking typically occurs during the slow-wave sleep stages 3 and 4 early in the night when the person is not dreaming, contradicting the myth that sleepwalkers are acting out their dreams.
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
1.4K
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

848
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
848
CNS Depressants: Barbiturates and Benzodiazepines01:14

CNS Depressants: Barbiturates and Benzodiazepines

1.7K
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Collagen-Coating Modulates Femtosecond Laser-Induced Autofluorescence and Morphological Changes in Human Fibroblasts.

Journal of biomedical materials research. Part B, Applied biomaterials·2025
Same author

Chronic trophic disorders in cocaine and heroin injectors: A multicenter retrospective observational descriptive study.

Annales de dermatologie et de venereologie·2024
Same author

Serum vitamin D concentrations in rabbits (Oryctolagus cuniculus) are more affected by UVB irradiation of food than irradiation of animals.

Veterinary journal (London, England : 1997)·2024
Same author

Kernel-based testing for single-cell differential analysis.

Genome biology·2024
Same author

[A guide to psychiatric prescribing in pregnancy, postpartum and breastfeeding].

L'Encephale·2023
Same author

Effect of femtosecond laser interaction with human fibroblasts: a preliminary study.

Lasers in medical science·2023

Related Experiment Video

Updated: Mar 30, 2026

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
07:35

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale

Published on: July 8, 2025

1.7K

Zolpidem test and catatonia.

H Javelot1, B Michel2, R Steiner3

  • 1Clinical Pharmacy Service - Mental Health Establishment (EPSAN), Brumath, France.

Journal of Clinical Pharmacy and Therapeutics
|November 9, 2015
PubMed
Summary

Zolpidem diagnostic and therapeutic tests offer a new treatment option for catatonia in schizophrenia. This approach provides an alternative to electroconvulsive therapy and may allow continued antipsychotic use.

Keywords:
catatoniaparanoid schizophreniazolpidemzolpidem test

More Related Videos

Manipulation of Epileptiform Electrocorticograms ECoGs and Sleep in Rats and Mice by Acupuncture
09:06

Manipulation of Epileptiform Electrocorticograms ECoGs and Sleep in Rats and Mice by Acupuncture

Published on: December 22, 2016

10.2K
Pentylenetetrazole-Induced Kindling Mouse Model
07:06

Pentylenetetrazole-Induced Kindling Mouse Model

Published on: June 12, 2018

35.4K

Related Experiment Videos

Last Updated: Mar 30, 2026

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
07:35

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale

Published on: July 8, 2025

1.7K
Manipulation of Epileptiform Electrocorticograms ECoGs and Sleep in Rats and Mice by Acupuncture
09:06

Manipulation of Epileptiform Electrocorticograms ECoGs and Sleep in Rats and Mice by Acupuncture

Published on: December 22, 2016

10.2K
Pentylenetetrazole-Induced Kindling Mouse Model
07:06

Pentylenetetrazole-Induced Kindling Mouse Model

Published on: June 12, 2018

35.4K

Area of Science:

  • Psychiatry
  • Neurology

Background:

  • Catatonia treatment lacks consensus, with recent advances including the zolpidem diagnostic and therapeutic test.
  • Lorazepam is a common treatment, but can be ineffective or inadequate for some catatonic patients.

Observation:

  • A case study of a patient with paranoid schizophrenia experiencing three catatonic episodes.
  • The patient's catatonia was unresponsive to lorazepam, highlighting the need for alternative treatments.

Findings:

  • The zolpidem diagnostic and therapeutic test demonstrated effectiveness in managing catatonic episodes.
  • This test offers a viable alternative for patients unresponsive to traditional treatments like lorazepam.

Implications:

  • Zolpidem testing presents a credible alternative to electroconvulsive therapy for catatonia.
  • This therapeutic approach may enable the continuation of essential antipsychotic medications during catatonia treatment.